
Home Blood Sample Collection Platform
On-demand certified phlebotomists visiting homes within 2 hours to collect blood and other samples for NABL-certified lab testing — with digital reports in 6-12 hours.
At a glance
Monthly Revenue
₹5L – ₹50L
Time to First Revenue
2 months
Break-even
14-20 months
Setup Cost
₹15L – ₹35L
Gross Margin
40%
Difficulty
Intermediate
Start Here — This Week
Partner with 2 NABL labs, train and certify 10 phlebotomists, build booking app, launch in one city
Home collection grew from 5% to 35% of diagnostics revenue during COVID and has remained elevated
Revenue Model
Free Download
Get the Full Launch Kit for this Idea
Detailed financial model · Supplier & vendor contacts · 90-day checklist · City-wise demand data
Things to Be Mindful Of
- 2-hour guaranteed arrival time is the key service promise that beats established players
- QR code sample tracking from collection to result builds trust and reduces "lost sample" customer complaints
Unit Economics
Real benchmarks from Indian operators in this space
Customer Acq. Cost
600
Lifetime Value
5400
LTV : CAC
9
Avg Order Value
800
Monthly Churn
25
CAC Payback
5
Per-collection ₹100 + test cost; annual health packages ₹2,000–₹5,000 reduce per-visit pricing.
Search Demand Trend
Google Trends — India — past 5 years
Indian Competitors & Players
Know your competition before you start
Key players
| Company | Scale / Revenue Signal |
|---|---|
Redcliffe Labs Indian Startup | Home sample collection + lab; rapidly growing. |
Lal PathLabs Listed Company | Dominant diagnostic chain; home collection added. |
PharmEasy Diagnostics Indian Startup | Integrated pharmacy + diagnostics. |
State Business Incentives
Capital subsidies, grants & sector incentives available in your state
Select a state above to see available incentives.
Real Founder Story
Sunil Sharma
SampleAt Home · Noida · 2020
Month 6
₹1.8L/month
Month 12
₹5.5L/month
Team size: 8 (4 phlebotomists, 4 ops)
What Worked
Elderly and diabetic patients need regular blood tests but can't travel. ₹100 home visit fee on top of lab cost — patients paid it happily. Partnered with 3 diagnostic labs in Noida as preferred collection channel.
Biggest Mistake
Single lab partnership limited tests available. Multi-lab empanelment (choose lab, we collect for all) expanded test menu 5x — order value up 60%.
Licenses & Registrations
Pros & Cons
Pros
- India diagnostics market at ₹90,000 crore; home collection growing 35% annually
- 1mg and PharmEasy have proven demand
- Franchise model enables rapid city expansion
Cons
- 1mg, PharmEasy, and Metropolis have large home collection networks
- Phlebotomist quality and punctuality are critical to trust
- NABL-accredited lab partnership required for credibility
Real-World Proof
India diagnostics market at ₹1.2 lakh crore; home collection growing 35% annually
— Post-COVID 40% of diagnostic tests requested are home-collected. 200 million chronic patients need regular testing.
1mg Home Diagnostics grows to 100 cities with ₹500 Cr revenue
— Tata-owned 1mg proves home sample collection is a ₹1,000 Cr+ opportunity in India.
Explore more
Browse all Health & Wellness business ideas
Help us improve this page
Spotted wrong data, a missing detail, or have a suggestion? We read every message.
What's your feedback about?
0 / 500
Sources & References6
- [1]FICCI Healthcare 2024 — India diagnostics market at ₹1.2 lakh crore; home collection growing 35% annually
- [2]Inc42 — 1mg Home Diagnostics grows to 100 cities with ₹500 Cr revenue
- [3]Unit Economics — Per-collection ₹100 + test cost; annual health packages ₹2,000–₹5,000 reduce per-visit pricing.
- [4]Google Trends — Search demand index — India, 5-year window
- [5]DPIIT Startup Recognition Database (Dec 2023) — Ministry of Commerce & Industry — DPIIT recognised startups
- [6]MCA21 Company Master Data — data.gov.in — Ministry of Corporate Affairs — registered MSME companies
People Also Viewed
Similar ideas other founders are exploring

Preventive Health Checkup Platform
Annual preventive health checkup subscriptions with personalised test packages, at-home sample collection, and doctor-explained reports — making preventive care a habit, not a crisis response.
Monthly Revenue
₹10L – ₹1Cr
First Revenue
3 months

Addiction Recovery Support Platform
Digital support platform for alcohol and substance use disorder recovery — combining clinical assessments, de-addiction psychiatrist consultations, and peer support communities for patients and families.
Monthly Revenue
₹2L – ₹15L
First Revenue
3 months

Dental Care Subscription Plan
India's first dental membership plan providing access to a network of dentists for routine cleanings, X-rays, and discounted procedures at a fixed monthly fee — making preventive dental care affordable.
Monthly Revenue
₹2L – ₹20L
First Revenue
3 months

Medical Second Opinion Platform
Platform connecting patients with senior specialist doctors in tier 1 cities and international medical centres for credible second opinions before major surgeries and cancer treatments.
Monthly Revenue
₹2L – ₹15L
First Revenue
2 months